HomeGIFOF • OTCMKTS
add
Grifols SA Preference Shares Class B
Nakaraang pagsara
$7.42
Sakop ng taon
$5.58 - $9.40
Market cap
5.97B USD
Average na Volume
10.00
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(EUR) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 1.79B | 12.24% |
Gastos sa pagpapatakbo | 376.78M | -3.08% |
Net na kita | 51.69M | -13.19% |
Net profit margin | 2.88 | -22.79% |
Kita sa bawat share | — | — |
EBITDA | 468.09M | 33.73% |
Aktuwal na % ng binabayarang buwis | 31.35% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(EUR) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 806.74M | 66.60% |
Kabuuang asset | 20.28B | -8.07% |
Kabuuang sagutin | 12.29B | -8.95% |
Kabuuang equity | 8.00B | — |
Natitirang share | 679.63M | — |
Presyo para makapag-book | 0.94 | — |
Return on assets | 4.22% | — |
Return on capital | 4.78% | — |
Cash Flow
Net change in cash
(EUR) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 51.69M | -13.19% |
Cash mula sa mga operasyon | 299.61M | 92.51% |
Cash mula sa pag-invest | -196.40M | -59.83% |
Cash mula sa financing | -1.56B | -1,860.81% |
Net change in cash | -1.47B | -3,652.69% |
Malayang cash flow | 243.60M | 627.76% |
Tungkol
Grifols, S.A. is a global healthcare company and manufacturer of plasma-derived medicines founded in Barcelona, Spain, in 1909. With a workforce of over 23,000employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over than 30.
Principally a producer of blood plasma–based products, a field in which it is the European leader and third largest worldwide, and other biopharmaceutical solutions, the company is also a leader in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, in addition to clinical diagnostic technologies. Its portfolio of solutions is designed to enhance safety from donation to transfusion. Grifols also provides high-quality biological supplies for life-science research, clinical trials and for manufacturing pharmaceutical and diagnostic products. Additionally, the company supply tools, information and services that enable hospitals, pharmacies and healthcare professionals to deliver expert medical care. Wikipedia
CEO
Itinatag
Nob 18, 1940
Website
Mga Empleyado
23,000